Clinical Trial Update: Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating alisporivir (Deb025) combined with boceprevir in African American patients with chronic hepatitis C genotype 1 was terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alisporivir (alisporivir)
• Boceprevir (boceprevir)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C | Phase 3 | Status: TERMINATED | Results posted: 2017-01-16